Target intelligence / Profile preview

Neurobeachin pseudogene 3 (NBEAP3)

Target
NBEAP3
Molecular classification
Other: pseudogene
01

Overview

Neurobeachin pseudogene 3 (NBEAP3) is a pseudogene in the human genome, meaning it is a segment of DNA that resembles a known gene (neurobeachin, or NBEA) but is non-functional and does not code for a functional protein. Pseudogenes generally arise from gene duplication or retrotransposition mechanisms and accumulate mutations that prevent them from producing active gene products. There is no evidence for protein expression or biological function for NBEAP3, and it is not implicated in human diseases, molecular signaling pathways, or drug action. NBEAP3 is listed in gene databases as a pseudogene and not a protein-coding gene or established therapeutic target. There is no evidence in public datasets, scientific literature, or disease gene catalogs suggesting NBEAP3 plays a role in disease, normal physiology, or as a pharmacological target. BCL8C is simply a database catalog name and is not an established functional gene or drug target name. The functional neurobeachin gene (NBEA), which is distinct from NBEAP3, encodes a multidomain neuronal protein involved in synaptic function and neurodevelopment, but NBEAP3 does not code for this or any other protein. Any attempt to use NBEAP3 as a therapeutic target or biomarker would be incorrect.

Other names
BCL8C
02

Mechanism of action

None (as it is not a therapeutic target or functional gene)

03

Biological functions

None (no known function)
04

Disease associations

None established (no validated disease association)
05

Safety considerations

None applicable (not a drug target, not therapeutically relevant)
06

Interacting drugs

None known or reported
07

Biomarkers

None known or reported

Beyond the preview

Go deeper on Neurobeachin pseudogene 3 (NBEAP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurobeachin pseudogene 3 (NBEAP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call